Reference number : 236-2018-2019-Q4-00054, amendment number : , agreement type : G, recipient legal name : Amoozegar, Farnaz, recipient country : CA, recipient province : AB, recipient city : Calgary, recipient postal code : T2N 1N4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 125000.0, agreement start date : 2019-03-01, agreement end date : 2020-02-29, description english : Cannabis for the Prophylactic Treatment of Migraine: a randomized double-blind placebo-controlled clinical trial, description french : Cannabis for the Prophylactic Treatment of Migraine: a randomized double-blind placebo-controlled clinical trial, expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada